DevLab bio partners with cssI lifesciences
LITHICUM, MD / CSSi LifeSciences, a global drug and medical device contract research organization (CRO), and DevLab bio, a CAP accredited and CLIA certified contract research laboratory, announced today their partnership to provide seamless and integrated regulatory and analytic testing and development services to medical device and drug companies seeking to commercialize novel technologies. CSSi…
BIO International Convention 2022
DevLab bio, a BIO member, attends the BIO International Convention in June 13-16 at San Diego. DevLab bio is your one source for Contract Research Services and Clinical Diagnostic (CDX) services and will bring your project to fruition while focusing on efficiency and quality results. Our multi-pronged capabilities provide a flexible and full-service approach to…
ASGCT 2022
DevLab bio attends the American Society of Gene and Cell Therapy 25th Annual Meeting on May 16-19, 2022 in Washington, D.C. to discuss partnering with therapeutics! #ASGCT22 Our CEO, Sam Sutton and Senior Scientist, Steven Rheiner, PhD, look forward to meeting you to discuss your outsourcing needs. DevLab bio also offers a variety of specialty…
DevLab bio awarded CAP Accreditation
COPPELL, TX, 12/21/2021 – DevLab, LLC is proud to announce that the College of American Pathologists (CAP) has awarded accreditation to DevLab, LLC, dba DevLab bio, by the Accreditation Committee due to results of an on-site inspection performed by the CAP Accreditation Program. The DevLab bio clinical laboratory provides diagnostic testing and supports its’ Contract…
ASCP 2021
DevLab bio is your one source for Contract Research Services and Clinical Diagnostic (CDX) services and w i l l bring your project to fruition while focusing on efficiency and quality results. Our multi-pronged capabilities provide a flexible and full-service approach to complement your business needs. Contract Research Services: From small, focused research projects to…
